216 related articles for article (PubMed ID: 32121487)
41. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
[TBL] [Abstract][Full Text] [Related]
42. Similar Active Sites and Mechanisms Do Not Lead to Cross-Promiscuity in Organophosphate Hydrolysis: Implications for Biotherapeutic Engineering.
Purg M; Elias M; Kamerlin SCL
J Am Chem Soc; 2017 Dec; 139(48):17533-17546. PubMed ID: 29113434
[TBL] [Abstract][Full Text] [Related]
43. Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs.
Lee N; Yun H; Lee C; Lee Y; Kim E; Kim S; Jeon H; Yu C; Rho J
J Microbiol Biotechnol; 2021 Jan; 31(1):144-153. PubMed ID: 33144547
[TBL] [Abstract][Full Text] [Related]
44. Differences in amino acid residues in the binding pockets dictate substrate specificities of mouse senescence marker protein-30, human paraoxonase1, and squid diisopropylfluorophosphatase.
Belinskaya T; Pattabiraman N; diTargiani R; Choi M; Saxena A
Biochim Biophys Acta; 2012 May; 1824(5):701-10. PubMed ID: 22401958
[TBL] [Abstract][Full Text] [Related]
45. Substrate Analogues for the Enzyme-Catalyzed Detoxification of the Organophosphate Nerve Agents-Sarin, Soman, and Cyclosarin.
Bigley AN; Harvey SP; Narindoshvili T; Raushel FM
Biochemistry; 2021 Sep; 60(38):2875-2887. PubMed ID: 34494832
[TBL] [Abstract][Full Text] [Related]
46. Theoretical Studies on Catalysis Mechanisms of Serum Paraoxonase 1 and Phosphotriesterase Diisopropyl Fluorophosphatase Suggest the Alteration of Substrate Preference from Paraoxonase to DFP.
Zhang H; Yang L; Ma YY; Zhu C; Lin S; Liao RZ
Molecules; 2018 Jul; 23(7):. PubMed ID: 29986514
[TBL] [Abstract][Full Text] [Related]
47. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase.
Ghanem E; Raushel FM
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):459-70. PubMed ID: 15982683
[TBL] [Abstract][Full Text] [Related]
48. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
[TBL] [Abstract][Full Text] [Related]
49. Binding modes of phosphotriesterase-like lactonase complexed with δ-nonanoic lactone and paraoxon using molecular dynamics simulations.
Guan S; Zhao L; Jin H; Shan N; Han W; Wang S; Shan Y
J Biomol Struct Dyn; 2017 Feb; 35(2):273-286. PubMed ID: 26775655
[TBL] [Abstract][Full Text] [Related]
50. A mixture of three engineered phosphotriesterases enables rapid detoxification of the entire spectrum of known threat nerve agents.
Despotović D; Aharon E; Dubovetskyi A; Leader H; Ashani Y; Tawfik DS
Protein Eng Des Sel; 2019 Dec; 32(4):169-174. PubMed ID: 31612205
[TBL] [Abstract][Full Text] [Related]
51. Variants of Phosphotriesterase for the Enhanced Detoxification of the Chemical Warfare Agent VR.
Bigley AN; Mabanglo MF; Harvey SP; Raushel FM
Biochemistry; 2015 Sep; 54(35):5502-12. PubMed ID: 26274608
[TBL] [Abstract][Full Text] [Related]
52. Enhanced degradation of chemical warfare agents through molecular engineering of the phosphotriesterase active site.
Hill CM; Li WS; Thoden JB; Holden HM; Raushel FM
J Am Chem Soc; 2003 Jul; 125(30):8990-1. PubMed ID: 15369336
[TBL] [Abstract][Full Text] [Related]
53. Reconstructing a missing link in the evolution of a recently diverged phosphotriesterase by active-site loop remodeling.
Afriat-Jurnou L; Jackson CJ; Tawfik DS
Biochemistry; 2012 Aug; 51(31):6047-55. PubMed ID: 22809311
[TBL] [Abstract][Full Text] [Related]
54. Evolution in the amidohydrolase superfamily: substrate-assisted gain of function in the E183K mutant of a phosphotriesterase-like metal-carboxylesterase.
Mandrich L; Manco G
Biochemistry; 2009 Jun; 48(24):5602-12. PubMed ID: 19438255
[TBL] [Abstract][Full Text] [Related]
55. QM/MM and MM MD simulations on decontamination of the V-type nerve agent VX by phosphotriesterase: toward a comprehensive understanding of steroselectivity and activity.
Fan F; Zheng Y; Fu Y; Zhang Y; Zheng H; Lyu C; Chen L; Huang J; Cao Z
Phys Chem Chem Phys; 2022 May; 24(18):10933-10943. PubMed ID: 35466335
[TBL] [Abstract][Full Text] [Related]
56. Crystallization and preliminary X-ray diffraction analysis of the hyperthermophilic Sulfolobus solfataricus phosphotriesterase.
Elias M; Dupuy J; Merone L; Lecomte C; Rossi M; Masson P; Manco G; Chabriere E
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jul; 63(Pt 7):553-5. PubMed ID: 17620708
[TBL] [Abstract][Full Text] [Related]
57. Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model.
Yeung DT; Josse D; Nicholson JD; Khanal A; McAndrew CW; Bahnson BJ; Lenz DE; Cerasoli DM
Biochim Biophys Acta; 2004 Oct; 1702(1):67-77. PubMed ID: 15450851
[TBL] [Abstract][Full Text] [Related]
58. A mesophilic phosphotriesterase-like lactonase shows high stability and proficiency as quorum quenching enzyme.
Marone M; Porzio E; Lampitella EA; Manco G
Chem Biol Interact; 2023 Sep; 383():110657. PubMed ID: 37573927
[TBL] [Abstract][Full Text] [Related]
59. Quantum dot display enhances activity of a phosphotriesterase trimer.
Breger JC; Walper SA; Oh E; Susumu K; Stewart MH; Deschamps JR; Medintz IL
Chem Commun (Camb); 2015 Apr; 51(29):6403-6. PubMed ID: 25764989
[TBL] [Abstract][Full Text] [Related]
60. The latent promiscuity of newly identified microbial lactonases is linked to a recently diverged phosphotriesterase.
Afriat L; Roodveldt C; Manco G; Tawfik DS
Biochemistry; 2006 Nov; 45(46):13677-86. PubMed ID: 17105187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
